Exigent Research Network Welcomes Nina Chavez as Senior Vice President of Growth

2026-06-05 · Source: The AI Journal · Field: Science & Research — Health & Medical Research, Life Sciences & Biology, Research Methodology & Innovation · Depth: Fundamental Awareness, quick

Summary

Exigent Research Network, a company focused on providing high-quality research opportunities to independent oncology practices nationwide, announced on June 5, 2026, that Nina Chavez has joined as Senior Vice President of Growth. Chavez brings over 20 years of experience, previously serving as Vice President of Strategic Partnerships & Alliances at Flatiron Health and Chief Operating Officer at New Mexico Cancer Center. Her background includes strengthening community oncology practices through strategic partnerships and operational leadership, having launched major initiatives like the Strategic Advisory Committee at Flatiron Health. Dr. Sibel Blau, Exigent's President and CEO, emphasized Chavez's commitment to empowering independent oncology practices and her ability to drive strategic growth. Chavez's leadership is expected to accelerate Exigent's next phase of expansion, broadening access to clinical research for community oncology practices and advancing cancer research and patient care through its unique network-based model, formed from a partnership between QCCA and NCCA.

Key takeaway

For oncology practice leaders seeking to expand clinical research opportunities, Exigent Research Network's appointment of Nina Chavez as SVP of Growth signals a strategic push to broaden access. Her extensive experience in strategic partnerships and operational leadership suggests Exigent will intensify efforts to bring innovative trials to community settings. You should monitor Exigent's upcoming initiatives and consider exploring potential collaborations to enhance patient care and research participation within your practice.

Key insights

Nina Chavez's appointment as SVP of Growth at Exigent Research Network aims to accelerate community oncology research access and partnerships.

Principles

• Strategic partnerships empower oncology practices.
• Operational leadership drives practice transformation.
• Democratize clinical research access.

Method

Exigent Research Network employs a network-based model, formed by QCCA and NCCA, to democratize clinical cancer research access at the point of care, bringing innovative trials to local communities.

Topics

• Exigent Research Network
• Nina Chavez
• Oncology Research
• Clinical Trials
• Strategic Partnerships
• Community Oncology

Best for: Entrepreneur, Executive, Investor, Domain Expert

Related on AIssential

• Demis Hassabis On What AI Will Do Next — AI is evolving into a co-creative partner, poised to accelerate scientific discovery and revolutionize human health within decades.
• GigaTIME: Scaling tumor microenvironment modeling using virtual population generated by multimodal AI — GigaTIME uses multimodal AI to convert common H&E slides into virtual mIF images, enabling population-scale precision immuno-oncology research.
• Enhancing success rates in therapeutic antibody design through generative models — DualGPT-AB is a dual-stage GPT framework optimizing therapeutic antibody design for specificity and developability.
• JASMINE — Early skin cancer detection in rural areas can be significantly improved with low-cost, offline, edge AI devices.
• Reinforcement learning-based design of sequential drug treatment targeting the evolving tumour landscape with SequenTx — SequenTx uses reinforcement learning and a virtual cell model to design effective sequential drug treatments for evolving tumors.
• AI Improving Dose Decisions and Patient Outcomes in Oncology- with Shefali Kakar of Novartis — AI-driven data integration refines oncology dose decisions, safety, and patient variability, accelerating drug development.

Open in AIssential →

Editorial summary, takeaway, and curation by AIssential. Original article published by The AI Journal.